These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21928718)

  • 1. Analysis of wet granulation process with Plackett-Burman design--case study.
    Woyna-Orlewicz K; Jachowicz R
    Acta Pol Pharm; 2011; 68(5):725-33. PubMed ID: 21928718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by design approach for formulation development: a case study of dispersible tablets.
    Charoo NA; Shamsher AA; Zidan AS; Rahman Z
    Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation.
    Badawy SI; Narang AS; LaMarche K; Subramanian G; Varia SA
    Int J Pharm; 2012 Dec; 439(1-2):324-33. PubMed ID: 22981985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New gentle-wing high-shear granulator: impact of processing variables on granules and tablets characteristics of high-drug loading formulation using design of experiment approach.
    Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Al-Shdefat RI
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1584-1600. PubMed ID: 28480773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of process parameters on compressibility of granulation manufactured in a high-shear mixer.
    Badawy SI; Menning MM; Gorko MA; Gilbert DL
    Int J Pharm; 2000 Mar; 198(1):51-61. PubMed ID: 10722950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
    Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
    Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time assessment of critical quality attributes of a continuous granulation process.
    Fonteyne M; Vercruysse J; Díaz DC; Gildemyn D; Vervaet C; Remon JP; De Beer T
    Pharm Dev Technol; 2013 Feb; 18(1):85-97. PubMed ID: 22023327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single process for manufacturing spheres with a lipid base (HCO).
    Gauthier P; Cardot JM; Beyssac E; Aiache JM
    Pharm Dev Technol; 2012; 17(3):303-14. PubMed ID: 21175264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface responses and desirability functions to determine optimal granulation domains.
    Giry K; Viana M; Genty M; Wüthrich P; Chulia D
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1016-26. PubMed ID: 20818964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Int J Pharm; 2004 Apr; 273(1-2):183-94. PubMed ID: 15010142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation.
    Aksu B; Paradkar A; de Matas M; Özer Ö; Güneri T; York P
    Pharm Dev Technol; 2013 Feb; 18(1):236-45. PubMed ID: 22881350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design I: Application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of "main factors" in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets.
    Fahmy R; Kona R; Dandu R; Xie W; Claycamp G; Hoag SW
    AAPS PharmSciTech; 2012 Dec; 13(4):1243-54. PubMed ID: 22993122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets.
    Fonteyne M; Wickström H; Peeters E; Vercruysse J; Ehlers H; Peters BH; Remon JP; Vervaet C; Ketolainen J; Sandler N; Rantanen J; Naelapää K; De Beer T
    Eur J Pharm Biopharm; 2014 Jul; 87(2):252-63. PubMed ID: 24589422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined experimental and modeling approach to study the effects of high-shear wet granulation process parameters on granule characteristics.
    Pandey P; Tao J; Chaudhury A; Ramachandran R; Gao JZ; Bindra DS
    Pharm Dev Technol; 2013 Feb; 18(1):210-24. PubMed ID: 22780851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of melt pelletization in a high shear mixer.
    Bukovec P; Kroselj V; Turk S; Vrecer F
    Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of evaluating the consolidation of granules manufactured by high shear mixer.
    Ohno I; Hasegawa S; Yada S; Kusai A; Moribe K; Yamamoto K
    Int J Pharm; 2007 Jun; 338(1-2):79-86. PubMed ID: 17321085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.